Türkiye to Utilize AI for Early Alzheimer’s Detection

Yeshim Aydin Son, a member of the Pedagogical Council of the Institute of Informatics at METU University and the Board of the Joint Center for Applied Research in Neuroscience and Neurotechnology (NÖROM), discussed this development in an interview with a correspondent from Anadolu Agency.

She explained that the technology interprets genetic testing using saliva samples. This breakthrough is expected to provide valuable support to doctors in the diagnostic process.

“Our system will be particularly beneficial for individuals over the age of 65 displaying symptoms of Alzheimer’s disease, such as memory loss,” she said. “After conducting genetic analysis, doctors can integrate the results with clinical observations to establish a diagnosis.”

Using artificial intelligence, the research team analyzed extensive datasets from international groups to identify genetic profiles indicative of early-stage Alzheimer’s risk.

“We extract DNA from saliva samples to identify genetic variations linked to a 1.5-2 times higher risk of developing the disease,” Son elaborated. “We have also developed a prototype molecular diagnostic kit as part of our project.”

The method underwent testing on a group of 100 Alzheimer’s patients, reaching the prototype stage. Son expressed the team’s desire to proceed to the project’s second phase.

Early and precise diagnosis is crucial for effective Alzheimer’s treatment, according to Son. While the degenerative brain processes cannot be prevented, strategies to slow down progression have emerged. Thus, the research holds significant promise for early intervention and improved patient outcomes.